Parathyroid hormone: A novel tool for treating bone marrow depletion in cancer patients caused by chemotherapeutic drugs and ionizing radiation

Cancer Letters

Volumn 244, Issue 1, 2006, Pages 8-15

  Whitfield, James F ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Bone marrow; Bone marrow transplants; Chemotherapy; Hematopoietic stem cells (HSCs); HSC niche; Osteoblasts; Parathyroid hormone (PTH); Parathyroid hormone receptor 1 (PTHR1); Radiation therapy; Trabecular bone lining cells; Transplant engraftment

Indexed keywords

ANGIOPOIETIN 1; ANTINEOPLASTIC AGENT; FLUOROURACIL; GANCICLOVIR; OSTABOLIN C; PARATHYROID EXTRACT; PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE;

BONE GROWTH; BONE MARROW DEPRESSION; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL STIMULATION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; HEMATOPOIESIS; HUMAN; IONIZING RADIATION; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL TRANSPLANTATION; TRABECULAR BONE; TREATMENT OUTCOME;

CUCURBITA; MURINAE;

EID: 33645765679     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.02.006     Document Type: Review

References (52)

1. J.F. Whitfield, Growing bone, Landes Bioscience, Eureka.com. Georgetown Texas, 2005.
2. Whitfield J.F. Parathyroid hormone and leptin-new peptides, expanding clinical prospects. Exp. Opin. Invest. Drugs 14 (2005) 251-264
3. Whitfield J.F., Bird R.P., Morley P., Willick G.E., Barbier J.R., MacLean S., and Ross V. The effects of parathyroid hormone fragments on bone formation and their lack of effects on the initiation of colon carcinogenesis in rats as indicated by preneoplastic aberrant crypt formation. Cancer Lett. 200 (2003) 107-113
4. Rixon R.H., Whitfield J.F., and Youdale T. Increased survival of rats irradiated with x- rays and treated with parathyroid extract. Nature 182 (1958) 1374
5. Selye H. On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16 (1932) 547-558
6. Rixon R.H., and Whitfield J.F. The radioprotective action of parathyroid extract. Int. J. Radiat. Biol. 3 (1961) 361-367
7. Perris A.D., Whitfield J.F., and Rixon R.H. Stimulation of mitosis in bone marrow and thymus of normal and irradiated rats by divalent cations and parathjyroid extract. Radiat. Res. 32 (1967) 550-563
8. Potts Jr. J.T., Tregear G.W., Keutmann H.T., Niall H.D., Sauer R., Deftos L.J., et al. Synthesis of a biologically active N-terminal tetratriacon tapeptide of parathyroid hormone. Proc. Natl Acad. Sci. USA 68 (1971) 63-67
9. Tregear G.W., van Rietschoten J., Greene E., Niall H.D., Keutmann H.T., Parsons J.A., et al. Solid-phase synthesis of the biologically active N-terminal 1-34 peptide of human parathyroid hormone. Hoppe. Seylers Z. Physiol. Chem. 355 (1974) 415-421
10. Mithal A., and Brown E.M. An overview of extracellular calcium homeostasis and the roles of the CaR in parathyroid and C-cells. In: Chattopadhyay N., and Brown E.M. (Eds). Calcium-Sensing Receptors (2003), Kluwer, Boston 1-27
11. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J. Pharmacol. Exp. Ther. 299 (2001) 323-331
12. Perris A., and Whitfield J.F. Calcium and the control of mitosis in the mammal. Nature 216 (1967) 1350-1351
13. Rixon R.H., and Whitfield J.F. The relation between the mitogenic and therapeutic actions of milk and sodium caseinate in X-irradiated mice. Radiat. Res. 40 (1969) 601-612
14. Rixon R.H., and Whitfield J.F. Hypoplasia of the bone marrow in rats following removal of the parathyroid glands. J. Cell. Physiol. 79 (1972) 343-352
15. Perris A.D., and Whitfield J.F. Calcium homeostasis and erythropoietic control in the rat. Can. J. Physiol. Pharmacol. 49 (1971) 22-35
16. Perris A.D., MacManus J.P., Whitfield J.F., and Weiss L.A. Parathyroid glands and mitotic stimulation in rat bone marrow after hemorrhage. Am J. Physiol. 220 (1971) 773-778
17. Swierenga S.H.H., MacManus J.P., Braceland B.M., and Youdale T. Regulation of the pri- mary immune response in vivo by parathyroid hormone. J. Immunol. 117 (1976) 1608-1611
18. Gallien-Lartigue O., and Carrez D. Induction in vitro de la phase S dans les cellules souches multipotentes de la moelle osseuse par l'hormone parathyroςdienne. C.R. Acad. Sci. D Paris 278 (1974) 1765-1768
19. Till J.E., and McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow. Radiat. Res. 14 (1961) 1419-1430
20. Stem cells: scientific progress and future research directions, Hematopoietic stem cells, Chapter 5. Department of Health and Human Services, 2001, http://stemcells.nih.gov/info/scireport
21. Becker A.J., McCulloch E.A., Siminovitch L., and Till J.E. The effect of differing demands for blood cell production on DNA synthesis by hemopoietic colony-forming cells of mice. Blood 26 (1965) 296-308
22. Byron J.W. Cyclic nucleotides and the cell cycle of the hematopoietic stem cell. In: Abou-Sabe M. (Ed). Cyclic Nucleotides and the Regulation of Cell Growth (1977), Dowden, Hutchinson & Ross, Stroudburg, PA 81-103
23. Schofield R. The relationship between the spleen colony-forming cell and haematopoietic stem cell. Blood Cells 4 (1978) 7-25
24. Schofield R. The pluripotent stem cell. Clin. Haematol. 8 (1979) 221-237
25. Nakorn T.N., Traver D., Weissman I.L., and Akashi K. Myoerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109 (2002) 1579-1585
26. Lord B.I. The architecture of bone marrow cell populations. Int. J. Cell Cloning 8 (1990) 317-331
27. c in the normal mouse femur. Blood 46 (1975) 65-72
28. Mason T.M., Lord B.I., and Hendry J.H. The development of spatial distributions of CFU-S and in vitro CFC in femora of mice of different ages. Br. J. Haematol. 73 (1989) 455-461
29. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., and Aguila H. Hemopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103 (2004) 3258-3264
30. Arai F., Hirao A., Omura M., Sato H., Matsuoka S., and Takubo K. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
31. Arai F., Hirano A., and Suda T. Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc. Med. 15 (2005) 75-79
32. Haylock D.N., and Nilsson S.K. Stem cell regulation by the stem cell niche. Cell Cycle 4 (2005) 1353-1355
33. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grηnewald E., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201 (2005) 1781-1791
34. Zhang J., Niu C., Yo L., Huang H., He X., Tong W.-G., et al. Indentification of the haematopoietic stem cell niche and control of niche size. Nature 425 (2003) 836-841
35. Zhu J., and Emerson S.G. A new bone to pick: osteoblasts and haematopoietic stem-cell niche. BioEsaays 26 (2004) 595-599
36. Moore K.A., and Lemischka I.R. 'Tie-ing' down the hematopoietic niche. Cell 118 (2004) 139-143
37. Whitfield J.F. Taming psoriatic keratinocytes-PTHs' uses go up another notch. J. Cell. Biochem. 93 (2004) 251-256
38. 0. Blood 96 (2000) 4185-4193
39. Brandon C., Eisenberg L.M., and Eisenberg C.A. WNT signaling modulates the diversifica- tion of hematopoietic cells. Blood 96 (2000) 4132-4141
40. Dazzi F., Ramasamy R., Glennie S., Jones S.P., and Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev. (2005) (published online November)
41. Reya T., Duncan A.W., Allies L., Domen J., Scherer D.C., Willert K., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
42. Staal F.J.T., and Clevers H.C. Wnt signalling and haematopoiesis: a Wnt-Wnt situation. Nat. Rev. Immunol. 5 (2005) 21-30
43. Van Den Berg D.J., Sharma A.K., Bruno E., and Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92 (1998) 3189-3202
44. Willert K., Brown J.B., Danenberg E., Duncan A.W., Weismann I.L., Reya T., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
45. Duncan A.W., Rattis F.M., Di Mascio L.N., Congdon K.L., Pazianos G., Zhao C., et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol. 6 (2005) 314-322
46. Marie P.J. Role of N-cadherin in bone formation. J. Cell. Physiol. 190 (2002) 297-305
47. Suva L.J., Towler D.A., Harada S., Lafage M.H., Steuckle S., and Rosenblatt M. Hormonal regulation of osteoblast-derived cadherin expression in vitro and in vivo. J. Bone Miner. Res. 9 (1994) S123
48. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
49. Suzuki T., and Chiba S. Notch signaling in hematopoietic stem cells. Int. J. Hematol. 82 (2005) 285-294
50. van Es J.H., van Gijn M.E., Riccio O., van den Born M., Vooijs M., Begthel H., et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435 (2005) 959-963
51. Rixon R.H., Whitfield J.F., and MacManus J.P. Stimulation of mitotic activity in rat bone marrow and thymus by exogenous adenosine 3′,5′-monophosphate (cyclic AMP). Exp. Cell Res. 63 (1970) 110-116
52. Dobnig H., and Turner R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136 (1995) 3632-3638